Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

ALACT

Acticor Biotech (ALACT)

Acticor Biotech
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:EU:ALACT
DataHoraFonteTítuloCódigoCompanhia
07/02/202414:00GlobeNewswire Inc.The University of Birmingham and Acticor Biotech announce the First Patient treated in LIBERATE, first clinical trial evaluating glenzocimab for heart attackEU:ALACTActicor Biotech
07/11/202306:34GlobeNewswire Inc.Acticor Biotech has just and timely completed patient recruitment of its phase 2/3 study in strokeEU:ALACTActicor Biotech
14/09/202313:15GlobeNewswire Inc.Acticor adapts its ACTISAVE clinical study to prepare the registration of glenzocimab for the treatment of strokeEU:ALACTActicor Biotech
 Apresentando as notícias mais relevantes sobre:EU:ALACT